Results 81 to 90 of about 1,041,462 (205)
Zdravniški Vestnik, 2001 Background. Hepatorenal syndrome (HRS) is acommon complication of advanced hepatic disease characterizedby marked abnormalities in arterial circulation and byrenal failure. An extreme arteriolar vasodilatation located inthe splanchnic circulation results
Matjaž Hafner
doaj
Acta Physiologica, Volume 242, Issue 9, September 2026.ABSTRACT Aim Patients with chronic kidney disease (CKD) have an increased cardiovascular risk. Since neutrophils and neutrophil‐borne proteins contribute to cardiovascular disease, we analyzed the neutrophil phenotype in patients with CKD who presented with a spectrum of cardiovascular comorbidities.
Sonja Vondenhoff +22 more
wiley +1 more source
Treatment Goals for Primary Biliary Cholangitis, an Australian Perspective
Journal of Gastroenterology and Hepatology, Volume 41, Issue 9, Page 2623-2638, September 2026.ABSTRACT Primary biliary cholangitis (PBC) is an autoimmune liver disease that targets the small intrahepatic bile ducts with diagnosis based on elevated serum alkaline phosphatase (ALP) levels and the presence of anti‐mitochondrial antibodies. Untreated, it may run a progressive course to cirrhosis and hepatic decompensation, at which point liver ...
Simone I. Strasser +6 more
wiley +1 more source
On the History of Hepatic Vein Catheterization
Liver International, Volume 46, Issue 9, September 2026.ABSTRACT Hepatic vein catheterization (HVC) in man was first performed 80 years ago in the wake of right‐sided heart catheterization. Several new methods, recognitions and concepts followed, especially the indirect Fick‐method for determination of splanchnic blood flow. Five years passed before pressure measurements were performed and routine HVCs were
Jens Henrik Henriksen +2 more
wiley +1 more source
[Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis]
, 2009 Ascites and hyponatremia are frequent complications of advanced liver cirrhosis. Over 50 % of cirrhotic patients develop ascites and about one third gets hyponatremic.
Ackermann, Daniel
core
Noradrenaline for reverting hepatorenal syndrome: a prospective, observational, single-center study
, 2018 Kamesh Gupta,1 Pooja Rani,1 Anurag Rohatgi,1 Mukesh Verma,1 Shivani Handa,2 Keemi Dalal,1 Anand Jain1 1Department of Internal Medicine, Lady Hardinge Medical College, New Delhi, India; 2Department of Gastroenterology, Liver Associates of Texas, Houston ...
Jain A +6 more
core
Principles of portal hypertension treatment at patients with liver cirrhosis
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2012 The aim of review. To describe modern principles of portal hypertension treatment in patients with liver cirrhosis (LC).Original positions. One of the most significant LC complications is portal hypertension - acute bleeding from varicose veins (VV) of ...
Ye. A. Fedosina +2 more
doaj
Cardiovascular Manifestations of Hepatorenal Syndrome [PDF]
Introduction: Hepatorenal syndrome (HRS) is a severe complication of liver cirrhosis and other advanced liver diseases, characterized by a rapid deterioration of renal function in patients with liver failure.
Thaís Augusta Quirino Esteves +9 more
core +1 more source
Long‐Term Albumin Therapy in Cirrhosis With Ascites: Not an Answer yet
United European Gastroenterology Journal, Volume 14, Issue 7, September 2026.
Adrià Juanola, Pere Ginès
wiley +1 more source
Acta Médica del Centro, 2016 Hepatorenal syndrome is a condition that occurs in patients with chronic liver disease characterized by portal hypertension and it is distinguished by the deterioration of renal function and marked abnormalities in blood circulation, with activation of ...
Raysa Garay Padrón +2 more
doaj